Verdad Advisers »

New York Times Company shares owned by Verdad Advisers

Quarter-by-quarter ownership of New York Times Company (NYT) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in New York Times Company

Tip: Access up to 7 years of quarterly data

All positions including New York Times Company held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in New York Times Company by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $629k 7.5k 83.73

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding New York Times Company

Berkshire Hathaway
BlackRock
Linonia Partnership
AQR Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Darsana Capital Partners
Geode Capital Management
Wellington Management Company
Baillie Gifford & Co
Renaissance Technologies
Dimensional Fund Advisors
Route One Investment Company
Capital World Investors

View all funds holding New York Times Company